Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Motor Activity 2Urologic Neoplasms 1Smoking Cessation 1Smoking 1Risk Reduction Behavior 1Postoperative Complications 1Patient Preference 1Obesity 1Malnutrition 1Kidney Neoplasms 1Disease 1Carcinoma, Renal Cell 1Alcohol Drinking 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Preoperative Exercise × Genitourinary × Clear all
NCT05480735 2022-10-31

ENHANCE

The Netherlands Cancer Institute

Phase NA Unknown
154 enrolled
Genitourinary

Urinary Bladder Neoplasms, Motor Activity, Smoking Cessation

NCT01836978 2018-03-22

Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
70 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡